Text Size

Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice

Shii D., Oda T., Shinomiya K., Katsuta O., Nakamura M.


  • 2009
  • Journal of Ocular Pharmacology and Therapeutics
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Preclinical development

  • Affiliations

    Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma-shi, Nara 630-0101, Japan

Related Publications

Multimodal Approach in Dry Eye Disease Combining In Vivo Confocal Microscopy and HLA-DR Expression

Blautain, B.; Rabut, G.; Dupas, B.; Riancho, L.; Liang, H.; Luzu, J.: Labbé, A.; Garrigue J.-S.; Brignole-Baudouin, F.; Baudouin, C.; Kessal, K.


Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.


Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022